OpenNeedle Ask your own

Question explored with the scientific record

side effects of diphenhydramine

Nov 21, 2026 · 7 sources used · OpenNeedle synthesis
The short version: diphenhydramine is a sedating, anticholinergic drug. Its side effects are real and dose-dependent, and the retrieved evidence covers only a slice of them.

The most reliable thing the evidence shows is sedation. In a randomized, double-blind crossover trial of 16 healthy adults, diphenhydramine at 150 mg a day increased daytime sleepiness and disrupted some daytime tasks, while loratadine did not [4]. That is the classic "first-generation" antihistamine problem: it crosses into the brain and makes you drowsy.

The second mechanism is anticholinergic activity. In a comparative lab study, diphenhydramine showed measurable anticholinergic potency, though weaker than cyproheptadine or promethazine [3]. Anticholinergic drugs are linked to confusion and memory problems, especially in older people. One small study found diphenhydramine 50 mg caused a modest drop in recall on a memory test [1], while another found no significant memory impairment at 25 or 50 mg despite clear sedation [2]. The memory evidence is mixed and thin.

The third is cardiac risk. A pharmacology review reports that diphenhydramine blocks potassium channels in the heart, a mechanism that can set up dangerous arrhythmias, especially at high doses or in overdose [5]. A case report describes a death involving multiple drugs including diphenhydramine, though fluoxetine was the primary culprit [6]. A case report also describes diphenhydramine-induced delirium in a patient with HIV-related cognitive problems [7].

EffectWhat the evidence shows
Daytime sleepinessIncreased at 150 mg/day [4]
Task performanceSome decrements [4]
MemoryMixed: modest drop at 50 mg [1], none at 25-50 mg [2]
Anticholinergic loadMeasurable, weaker than some others [3]
Heart rhythm riskPotassium channel blockade, arrhythmia risk [5]

What this retrieval cannot see: rates of these effects in real-world use, long-term cognitive risk from chronic use, and overdose thresholds. Those are not in these records.

My call: diphenhydramine is a genuinely sedating drug with a real anticholinergic and cardiac profile, and the evidence here supports caution, especially in older people and at higher doses. Confidence: moderate on sedation and cardiac mechanism, low on memory effects.

Keep digging

Sources used 7

  1. Identification of Medications That Cause Cognitive Impairment in Older People: The Case of Oxybutynin Chloride Journal of the American Geriatrics Society (1998) Thin

    This study evaluates the cognitive effects of oxybutynin hydrochloride in older adults, demonstrating significant cognitive impairment compared to diphenhydramine and highlighting the need for monitoring cognitive performance in patients prescribed this medication.

    DOI: 10.1111/j.1532-5415.1998.tb01006.x
  2. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine Psychopharmacology (1998) Thin

    This study investigates the differential effects of scopolamine, lorazepam, and diphenhydramine on memory and event-related potentials (ERPs) in healthy participants, revealing that while both scopolamine and lorazepam impair memory, diphenhydramine does not, despite similar sed…

    DOI: 10.1007/s002130050482
  3. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models European Journal of Pharmacology (2005) Thin

    This study evaluates the comparative anticholinergic activities of 10 antihistamines using in vitro and in vivo models, revealing significant differences in their potencies and effectiveness.

    DOI: 10.1016/j.ejphar.2004.11.006
  4. Sedative effects of antihistamines Journal of Allergy and Clinical Immunology (1987) Thin

    The study compared daytime sedative effects of the non-sedating antihistamine loratadine (10 mg and 40 mg) with the sedating antihistamine diphenhydramine (150 mg/day) and placebo in 16 healthy adults, finding loratadine did not cause clinically meaningful daytime sleepiness or …

    DOI: 10.1016/S0091-6749(87)80197-5
  5. Cardiotoxic potential and CNS effects of first-generation antihistamines Trends in Pharmacological Sciences (2000) Thin

    This study investigates the cardiotoxic potential of first-generation antihistamines, particularly hydroxyzine and diphenhydramine, highlighting their ability to block K+ channels and the associated risks of cardiac arrhythmias.

    DOI: 10.1016/s0165-6147(99)01437-6
  6. Rapid Ascending Sensorimotor Paralysis, Hearing Loss, and Fatal Arrhythmia in a Multimorbid Patient due to an Accidental Overdose of Fluoxetine Case Reports in Neurological Medicine (2017) Thin

    This is a single-patient case report describing rapid ascending sensorimotor paralysis, hearing loss, respiratory failure, cardiac arrest, and death in a multimorbid woman following an accidental overdose of fluoxetine with multiple coingestants, detailing toxicology findings, a…

    DOI: 10.1155/2017/5415243
  7. Diphenhydramine-induced delirium on top of HIV-associated neurocognitive disorder European Psychiatry (2023) Thin

    In a 60-month cohort of older inpatients with delirium requiring psychiatric care, 40.6% without previous dementia died in year one and 52.9% of one-year survivors later developed dementia, supporting delirium as a risk marker for dementia and death.

    DOI: 10.1192/j.eurpsy.2023.860

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →